ARVO ANNUAL MEETING, HONOLULU, APRIL 29- MAY 03, 2018
In a rapidly changing world, eye and vision researchers are emerging from the lab and the clinic to engage the public, patients and policymakers regarding the sight-saving work that we do and the benefits it brings to our societies. Our passion for our work and commitment to evidence-based science and medicine empower these conversations as they occur around the world. Engage with your colleagues as we work to advance our science and expand its support within our communities and governments.
"Big Data" is a big buzzword in healthcare today. The use of Big Data for improving healthcare outcomes and controlling costs shows significant promise. This course will help participants define what Big Data is, describe the Big Data sets available in vision research, explain the analytic methods behind Big Data, and summarize the potential applications of Big Data. This activity's overall purpose is to ensure change in learner competence by uncovering associations, patterns and trends with the data, in order to improve professional practice.
In the current era of personalized medicine, a large number of genetic variants in patients with various diseases using next generation sequencing have been identified. Recent advances in genetic engineering, genotyping, high-resolution imaging and biomarker testing have made it easier to deliver the right treatments to the right patients at the right time. This course presents an overview of CRISPR technology from the leading experts who have pioneered it in other disciplines, followed by examples in eye and vision science and practical applications. This course is designed to enhance learner competence in the area of CRISPR technology in order to appropriately apply in the learner's professional practice.
Inherited retinal diseases are a group of eye disorders caused by an inherited gene mutation and can cause vision loss or blindness. The primary goal of this course is to discuss opposing viewpoints related to the various treatment strategies for inherited retinal diseases. Further, learners will be able to identify and debate different clinical and research topics in the area of inherited retinal diseases. Emphasized will be perspectives on the use of stem cells and gene-directed therapy. In addition, the primary mechanism of retinal degeneration in patients with Stargardt disease will be discussed. These discussions highlight current obstacles clinician-scientists are facing in their fight against retinal degeneration. The overall goal of this course is to enhance learner competence in the area of retinal degeneration to utilize in professional practice.
Age-related macular degeneration (AMD) is one of the most common eye conditions leading to vision loss among people age 50 and older. In fact, the risk of acquiring advanced age-related macular degeneration increases from 2% for those ages 50-59, to nearly 30% for those over the age of 75. This course will examine key clinical and pathological findings in AMD. New insights into the genetics of AMD will be highlighted, including an in-depth discussion regarding the discovery of key biochemical pathways involved in the disease. Potential new therapies that could interrupt these pathways will also be explored. This course's overall aim is to enhance learner competence in the area of AMD to utilize in professional practice.